Clinical Trials Update: Dec. 6, 2010
Facial Acne HIV Migraine
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
This study is for people aged 12 to 45 with moderate-to-severe facial acne. Participants may qualify for compensation up to $300.
The research site is in Bryan, Texas.
This study will evaluate kd-247, a humanized monoclonal antibody, in people with HIV-1 infection who lack symptoms and are not receiving current antiretroviral therapy.
The research site is in Tamarac, Fla.
This study will compare different FDA-approved treatment options for acute migraines.
The research site is in Charleston, S.C.
Copyright 2010 ClinicalConnection.com. All rights reserved.